Urgent.News

What's breaking now, across thousands of outlets.

Business

Finance influencer V Harish dies by suicide; father alleges cyberbullying

The family has accused a venture studio CEO of online harassment. The CEO denies the allegation and says he had questioned Harish's financial regulatory credentials.

Finance influencer V Harish dies by suicide; father alleges cyberbullying

Financial influencer V Harish, who had amassed over a million followers, took his own life in a rented villa near Chennai. His father has accused Jason Samuel, CEO of venture studio Zemuria Inc., of cyberbullying his son. The dispute between the two began when Samuel, on X, accused Harish of misrepresenting his credentials and lacking a valid SEBI license, though Samuel denies any cyberbullying.

Harish's Instagram account was suspended following the allegations, and he subsequently started posting videos on a new social media platform. Samuel expressed deep sorrow over the loss but strongly refuted the cyberbullying accusations. His father, seeking a police investigation, claims that the online conflict had put immense stress on his 27-year-old son, ultimately leading to his tragic end.

The Tambaram police have added an abetment to suicide charge under Section 108 of the Bharatiya Nyaya Sanhita (BNS) to their ongoing investigation.

Written by urgent.news from YourStory's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at yourstory.com →

More in Business

Wage Gap Between Regular and Non-Regular Workers Widens

The difference in the monthly average wage between regular and non-regular workers widened further to 1,940,000 won (about $1,464) this year, recording the largest gap ever.According to the ‘Results…

  • Wage gap between regular and non-regular workers in South Korea hits record high
  • Non-regular workers earn 1,940,000 won/month, 76.5% less than regular workers
  • 38.5% of wage earners are non-regular, up from 38.4% last year

Samsung Bioepis Signs Exclusive Brazilian Supply Deal

Samsung Episholdings disclosed on Oct. 21 that its subsidiary Samsung Bioepis signed an exclusive supply contract for “SB12” through the Productive Development Partnership (PDP) project led by the…

  • Samsung Bioepis signs exclusive supply deal for SB12 biosimilar in Brazil.
  • SB12 is biosimilar to Alexion's rare disease treatment Soliris (eculizumab).
  • Deal part of Brazil's Productive Development Partnership program.

More from Wednesday 21 October →